Rheumatoid Arthritis Terminated Phase 3 Trials for Tabalumab (DB11657)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

DBCOND0027961 (Rheumatoid Arthritis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01215942An Open Label Study for Participants With Rheumatoid ArthritisTreatment
NCT01202773A Study in Participants With Rheumatoid ArthritisTreatment
NCT01198002A Rheumatoid Arthritis Study in Participants on a Background Treatment of MethotrexateTreatment
NCT01676701Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)Treatment